ReviewBritish journal of pharmacology2008
Drugs in sport: a scientist-athlete's perspective: from ambition to neurochemistry.
Review in British journal of pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Are We Reaching the Limits ofFrontiers in physiology · 2017Review
- Has Athletic Performance Reached its Peak?Sports medicine (Auckland, N.Z.) · 2015Review
- Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF?British journal of pharmacology · 2014Review
- Attitudes and motivations of competitive cyclists regarding use of banned and legal performance enhancers.Journal of sports science & medicine · 2014Article
- Mechanisms governing the health and performance benefits of exercise.British journal of pharmacology · 2013Review
- From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?Sports medicine (Auckland, N.Z.) · 2013Review
- The evolving science of detection of 'blood doping'.British journal of pharmacology · 2012Review
- Drugs in sport.British journal of pharmacology · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article, by the United Kingdom's last Olympic Marathon Medal winner, Charlie Spedding, and his brother, the pharmacologist, Michael Spedding, covers the difficulties posed by the availability of powerful drugs to ameliorate athletic performance, from an athlete's perspective, particularly in view of the fact that performances are becoming highly optimised with less margin for further physiological improvement. The authors have had long athletic careers and argue that doping not only devalues performance but sport, and exercise, as a whole. Furthermore, the neurotrophic and metabolic changes involved in exercise and training, which can be modified by drugs, are central to health and reflect a part of the epidemic in obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.